4.4 Article

Atrial Fibrillation and Obesity Reverse Remodeling of Atrial Substrate With Weight Reduction

Journal

JACC-CLINICAL ELECTROPHYSIOLOGY
Volume 7, Issue 5, Pages 630-641

Publisher

ELSEVIER
DOI: 10.1016/j.jacep.2020.11.015

Keywords

atrial fibrillation; connexin; endothelin; epicardial fat; obesity; TGF-beta 1; weight loss

Funding

  1. Centre of Heart Rhythm Disorders at the University of Adelaide
  2. University of Adelaide
  3. Mid-Career Fellowships from The Hospital Research Foundation
  4. Robert J. Craig Lectureship from the University of Adelaide
  5. National Health and Medical Research Council Senior Research Fellowship
  6. Monash University MBio Postgraduate Discovery Scholarship
  7. Practitioner Fellowships from the National Health and Medical Research Council
  8. National Heart Foundation of Australia
  9. Abbott
  10. Medtronic
  11. Bayer
  12. Boston Scientific
  13. Microport

Ask authors/readers for more resources

The study evaluated the effect of weight loss on the atrial substrate for atrial fibrillation in sheep with sustained obesity. Weight loss of 30% was associated with structural and electrophysiological reverse remodeling and reduced propensity for AF. These findings suggest the direct role of obesity in AF substrate and the potential benefit of weight reduction in patients with AF.
OBJECTIVES This study sought to evaluate the effect of weight loss on the atrial substrate for atrial fibrillation (AF). BACKGROUND Whether weight loss can reverse the atrial substrate of obesity is not known. METHODS Thirty sheep had sustained obesity induced by ad libitum calorie-dense diet over 72 weeks. Animals were randomized to 3 groups: sustained obesity and 15% and 30% weight loss. The animals randomized to weight loss underwent weight reduction by reducing the quantity of hay over 32 weeks. Eight lean animals served as controls. All were subjected to the following: dual-energy x-ray absorptiometry, echocardiogram, cardiac magnetic resonance, electrophysiological study, and histological and molecular analyses (fatty infiltration, fibrosis, transforming growth factor beta 1, and connexin 43). RESULTS Sustained obesity was associated with increased left atrium (LA) pressure (p < 0.001), inflammation (p < 0.001), atrial transforming growth factor b1 protein (p < 0.001), endothelin-B receptor expression (p = 0.04), atrial fibrosis (p = 0.01), epicardial fat infiltration (p < 0.001), electrophysiological abnormalities, and AF burden (p = 0.04). Connexin 43 expression was decreased in the obese group (p = 0.03). In this obese ovine model, 30% weight reduction was associated with reduction in total body fat (p < 0.001), LA pressure (p = 0.007), inflammation (p < 0.001), endothelin-B receptor expression (p = 0.01), atrial fibrosis (p = 0.01), increase in atrial effective refractory period (cycle length: 400 and 300 ms; p < 0.001), improved conduction velocity (cycle length: 400 and 300 ms; p = 0.01), decreased conduction heterogeneity (p < 0.001), and decreased AF inducibility (p = 0.03). Weight loss was associated with a nonsignificant reduction in epicardial fat infiltration in posterior LA (p = 0.34). CONCLUSIONS Weight loss in an obese ovine model is associated with structural and electrophysiological reverse remodeling and a reduced propensity for AF. This provides evidence for the direct role of obesity in AF substrate and the role of weight reduction in patients with AF. (C) 2021 Published by Elsevier on behalf of the American College of Cardiology Foundation. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.4
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available